Clinical trial
CHACO Study: Control of Arterial Hypertension in Colombian Patients
NCT04094714 is registered in ClinicalTrials.gov with Scandinavia Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CHACO Study: Control of Arterial Hypertension in Colombian Patients
- Lead sponsor
- Scandinavia Pharma
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 27, 2019
- Completion date
- July 31, 2024
- Enrollment
- 1,100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.